Comparison of quality of life (QOL) of patients with acute myelogenous leukemias (AML) in long-term first complete remission (CR) after bone marrow transplantation (BMT) - Allogeneic or autologous - Or intensive chemotherapy consolidation (ICC): EORTC-GIMEMA AML 8A study

Zittoun, R; Suciu, Stefan; Solbu, G; Watson, M.; Muus, P.; Mandelli, F.; Stryckmans, P.; Peetermans, M; Thaler, J; Willemze, R.

Comparison of quality of life (QOL) of patients with acute myelogenous leukemias (AML) in long-term first complete remission (CR) after bone marrow transplantation (BMT) - Allogeneic or autologous - Or intensive chemotherapy consolidation (ICC): EORTC-GIMEMA AML 8A study

Zittoun, R

;

Suciu, Stefan

;

Solbu, G

;

Watson, M.

;

Willemze, R.

;et.al.

(1995)

Files

No attached file found for this publication.

Details

Authors

Zittoun, R
Author
Suciu, StefanUCLouvain
Author
Solbu, G
Author
Watson, M.
Author
Willemze, R.
Author

Affiliations

UCLouvain

Citations

APA
Chicago
FWB

Zittoun, R., Suciu, S., Solbu, G., Watson, M., Muus, P., Mandelli, F., Stryckmans, P., Peetermans, M., Thaler, J., & Willemze, R. (1995). Comparison of quality of life (QOL) of patients with acute myelogenous leukemias (AML) in long-term first complete remission (CR) after bone marrow transplantation (BMT) - Allogeneic or autologous - Or intensive chemotherapy consolidation (ICC): EORTC-GIMEMA AML 8A study. Blood, 86(10), 1718. (Original work published 1995)